ASS STADA

Quick links to important sections

ASS STADA

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of ASS STADA

What is ASS STADA?

ASS STADA is a medication containing acetylsalicylic acid as its active ingredient. This substance belongs to a group of medicines known as platelet aggregation inhibitors. Its primary function is to help prevent blood cells from sticking together and forming clots.

Therapeutic Purpose

The medication is used to inhibit the formation of blood clots in the arteries, which can help reduce the risk of serious cardiovascular events. By thinning the blood slightly and preventing the aggregation of platelets, it supports the maintenance of healthy blood flow through constricted or damaged vessels.

Clinical Applications

It is commonly utilized in the following scenarios:

  • Secondary Prevention: Reducing the risk of a secondary event in individuals who have already experienced a heart attack or stroke.
  • Vascular Health: Assisting in the management of cardiovascular stability after certain surgical procedures or interventions on blood vessels.
  • Risk Reduction: Use in specific medical contexts where there is a documented high risk of clot formation in the circulatory system.

Unlike higher doses of acetylsalicylic acid, which are used for pain relief or fever reduction, the low dosage found in ASS STADA is specifically intended for long-term cardiovascular protection.

Regulatory References

  1. STADA Arzneimittel AG
  2. pharmacological studies
  3. solid pharmaceutical excipients
  4. solid oral dosage form
  5. anti-thrombotic effect

What side effects are possible with ASS STADA?

Possible Side Effects and Safety Information

The safety profile of ASS STADA, which contains Acetylsalicylic acid (ASS), is primarily defined by its effects on the gastrointestinal system and blood coagulation, consistent with its classification as an NSAID and antiplatelet agent. Adverse reactions are classified according to frequency as documented in official regulatory labeling.

Officially Documented Adverse Reactions

Classification System-Organ Class Examples of Reactions
Common Gastrointestinal Disorders Dyspepsia, nausea, vomiting, and minor gastrointestinal blood loss.
Common Blood and Lymphatic Disorders Increased bleeding tendencies, such as easy bruising or nosebleeds.
Uncommon Immune System Disorders Hypersensitivity reactions, including urticaria (hives).
Rare Nervous System Disorders Intracranial hemorrhage (bleeding in the brain).
Rare Hepato-biliary Disorders Reye's syndrome (in specific pediatric contexts).

Serious adverse reactions listed in regulatory documents include gastrointestinal ulceration and perforation, severe hemorrhage, anaphylactic shock, and rare but severe skin reactions (e.g., Stevens-Johnson syndrome). The risk of gastrointestinal bleeding or ulceration can occur at any time during treatment, and risk is associated with increasing doses.

Safety Considerations for Specific Populations

Official labeling defines specific safety constraints for certain groups. The use of ASS is contraindicated in children and teenagers with viral illness due to the risk of Reye's syndrome, a rare but serious condition. It is also contraindicated during the last three months of pregnancy due to risks of fetal toxicity and maternal/neonatal bleeding complications. Additionally, the risk of serious adverse reactions, especially gastrointestinal bleeding, is increased in older adults.

Overdose and Emergency Response

Overdose Map: Overdose and when to seek help — official regulatory information for ASS STADA

Overdose scope Documented overdose presentations: Initial toxicity, known as salicylism, is documented to include symptoms such as tinnitus (ringing in the ears), nausea, vomiting, sweating, and rapid breathing (hyperventilation). Severe toxicity can progress to confusion, hallucinations, hyperpyrexia (fever), seizures, and coma. Physiological systems affected (as stated in label): Severe effects involve the Central Nervous System, Cardiovascular System (hypotension, failure), and Metabolic System (critical high anion gap metabolic acidosis). Dose-related or exposure-related factors (if applicable): Acute ingestion of a dose greater than approximately 150 mg/kg is cited as warranting immediate medical evaluation. Chronic toxicity is noted in the elderly. Population-specific overdose notes (if applicable): Increased risk and severity are documented in pediatric patients. Emergency-response statements (as written in official documents): Contact a Poison Control Center immediately. Transfer to a hospital is required for medical evaluation and management. When immediate medical help is required (label-derived phrasing only): Seek immediate medical attention for any suspected overdose or onset of the documented symptoms.

Overdose classifications (high-level) Severity classification (as defined in official documents): Classified from Mild Toxicity (Salicylism) to Severe/Life-Threatening Toxicity. Regulatory basis (EMA / FDA / etc.): Information is consistent with official regulatory prescribing and clinical guidance documents. Overdose-context constraints (as defined in official documents): No specific antidote is known. Management focuses on supportive care and enhanced elimination.

Resulting overdose structure Official overdose statements: • The presence of tinnitus is recognized as an early clinical sign of salicylate toxicity. • Severe overdose is associated with life-threatening outcomes including cerebral edema, convulsions, and metabolic acidosis. • Specific procedures listed for management include activated charcoal, urinary alkalization, and hemodialysis for severe cases.

Connection to the overall overdose profile (2–4 sentences): Regulatory documents define the ASS overdose profile by documenting the progression from early clinical signs to critical systemic failure, triggered by toxic exposure. The profile mandates that individuals seek immediate medical attention and specifies the official medical procedures, such as urinary alkalization and hemodialysis, required for supportive care and drug elimination.

Therapeutic Uses of ASS STADA

Main Uses and Therapeutic Areas

ASS STADA is primarily used for its antiplatelet properties, which help to prevent the formation of blood clots within the vascular system. By inhibiting the aggregation of platelets, the medication supports the maintenance of blood flow in several clinical contexts.

Cardiovascular Protection

The medication is frequently utilized as part of a long-term management strategy for individuals with established cardiovascular conditions. Its primary roles include:

  • Secondary Prevention of Myocardial Infarction: Reducing the risk of a recurrent heart attack in patients who have previously experienced one.
  • Management of Unstable Angina: Assisting in the stabilization of blood flow in patients with acute chest pain caused by reduced oxygen supply to the heart muscle.
  • Prevention of Stroke: Reducing the incidence of ischemic strokes and transient ischemic attacks (TIAs) by preventing clots from blocking arteries supplying the brain.

Post-Surgical Applications

Following specific surgical procedures on the heart or blood vessels, ASS STADA is used to ensure the patency of the newly treated areas. This includes:

  • Arterial Interventions: Prevention of blood clots after coronary artery bypass grafting (CABG) or percutaneous transluminal coronary angioplasty (PTCA).
  • Vascular Shunts: Maintaining blood flow through synthetic or natural grafts used to treat vascular disease.

Benefits and Mechanism

The primary benefit of this therapy is the long-term reduction in the risk of major vascular events. By interfering with the biochemical processes that lead to platelet clumping, the medication helps to keep the blood thin and flowing more freely through narrowed or damaged vessels. This systemic effect is a cornerstone in the management of chronic arterial disease and the prevention of complications associated with atherosclerosis.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

The eligibility for using ASS STADA, an Acetylsalicylic acid (ASS) product, is strictly defined by regulatory authorities based on age, physiological status, and pre-existing medical conditions.

Contraindicated Populations (Must Not Use)

Use of ASS STADA is absolutely contraindicated for:

  • Patients with known hypersensitivity to ASS, salicylates, or other Nonsteroidal Anti-inflammatory Drugs (NSAIDs).
  • Those with active peptic ulcer disease, a history of gastrointestinal bleeding, or bleeding disorders (hemorrhagic diathesis).
  • Patients experiencing severe hepatic (liver) or renal (kidney) failure.
  • Women in the third trimester of pregnancy (typically from 30 weeks).
  • Children and adolescents with suspected or active viral infections (e.g., flu or chickenpox) due to the documented risk of Reye's Syndrome.

Age and Conditional Eligibility

  • Children under 16 years of age should not use this medicine for general pain or fever relief unless specifically directed by a physician.
  • Older adults require use with caution due to a higher official risk of gastrointestinal adverse events.
  • During the first and second trimesters of pregnancy, use is restricted and permitted only if deemed clearly necessary by a physician.
  • For breastfeeding women, occasional use is generally acceptable, but regular or high-dose use is not recommended as ASS passes into breast milk.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation structures the interaction profile of Acetylsalicylic acid (ASS) based on several critical pharmacodynamic and pharmacokinetic patterns.

Contraindicated Combinations and Restrictions

Co-administration with Methotrexate at doses of 15 mg/week or greater is contraindicated due to the risk of increased Methotrexate plasma concentrations. Combination with other Nonsteroidal Anti-inflammatory Drugs (NSAIDs), such as Ibuprofen or Naproxen, is also contraindicated because of the additive and officially documented risk of severe gastrointestinal bleeding. Similarly, certain herbal ingredients and medications like Cidofovir, Ketorolac, and Probenecid are explicitly restricted for use with ASS.


Documented Exposure and Pharmacodynamic Effects

ASS exhibits pharmacodynamic interactions with Anticoagulants and Antiplatelet Agents, resulting in an increased risk of hemorrhage due to additive effects. Systemic Corticosteroids also increase the risk of severe GI bleeding. Conversely, ASS may diminish the hypotensive effect of certain Antihypertensive medications, including ACE inhibitors and Diuretics. Additionally, the elimination of Salicylic acid is enhanced by systemic Glucocorticoids, resulting in reduced ASS exposure.


Timing and Substance Interactions

Regulatory documents mandate a timing-based separation when co-administering immediate-release ASS with Ibuprofen; ASS must be taken at least 2 hours before or 8 hours after Ibuprofen to preserve ASS's beneficial effects. Furthermore, chronic, heavy consumption of Alcohol (Ethanol) is documented to increase the risk of stomach bleeding.

Mechanism of Action

The mechanism of Acetylsalicylic acid (ASS) is characterized by its ability to interfere with the body's production of key chemical messengers through the targeted inhibition of the Cyclooxygenase (COX) enzyme family. This molecular action initiates distinct effects across two major physiological systems.

Molecular Targeting of the COX Enzyme Cascade

The mechanism involves the irreversible acetylation of the COX-1 enzyme and reversible inhibition of COX-2. This molecular action impedes the Arachidonic Acid Cascade, slowing the conversion of arachidonic acid into eicosanoid mediators. The inhibition of PGE2 synthesis modulates nociceptive signaling pathways and affects the central control of body temperature.

Sustained Modulation of Platelet Activation

By permanently inactivating the COX-1 enzyme in platelets, ASS stops the synthesis of Thromboxane A2 ( TXA2), a powerful pro-aggregatory messenger. Since platelets are anucleated and cannot synthesize new enzyme, this functional impairment persists for the lifespan of the platelet, influencing the body's natural processes of forming blood clots in the vascular system.

Dosage and Administration Information

Instruction Map: How to use ASS STADA — Administration Guidelines

This map details the administration and dosing instructions for the oral, gastro-resistant tablet formulation of Acetylsalicylic acid (ASS).


Administration Scope

Feature Guideline
Route of administration Oral use only. The product is supplied as a tablet.
Dosing schedule Long-Term Prophylaxis: The typical maintenance dose is 100 mg once daily. Analgesic/Antipyretic: Doses range from 300 mg to 650 mg every 4 to 6 hours, not to exceed 4000 mg (4 g) in 24 hours.
Timing in relation to meals (if applicable) May be taken with or after meals with sufficient liquid, such as a full glass of water.
Preparation requirements (if applicable) No preparation or dilution is required; the tablet is taken as supplied.
Age-group administration rules The use of Acetylsalicylic acid is generally restricted for children and adolescents under 16 years of age, unless explicitly prescribed by a medical professional.
Missed-dose rules If a scheduled dose is missed, it should be skipped entirely if it is almost time for the next dose, and the patient should resume the normal dosing schedule; do not double the dose.
Special procedural conditions The gastro-resistant tablet must be swallowed whole and must not be crushed, broken, or chewed.

Instruction Classifications (High-Level)

Classification Pattern
Administration method type Oral
Frequency pattern Daily (long-term) or As-needed (short-term)
Standard alignment National regulatory standards.
Use-context constraints Use is categorized as either Long-term prophylaxis or Short-term symptomatic administration.

Resulting Procedural Structure

Step sequence:

  • Intake: Administer the prescribed 100 mg dose once daily, or the 300 mg to 650 mg dose every 46 hours as needed.
  • Action Constraint: Ingest the tablet unaltered, without physically manipulating the gastro-resistant coating.
  • Fluid and Timing: Swallow the tablet whole with water, preferably during or following a meal.

Connection to the Overall Use Protocol

Instructions establish two distinct usage protocols for Acetylsalicylic acid: a fixed, once-daily, low-dose regimen for long-term administration, and an intermittent, higher-dose regimen for short-term administration. These guidelines define the specific frequency and duration patterns, alongside the procedural constraint that the gastro-resistant tablet must be swallowed whole to ensure proper delivery.

Recent Clinical Evidence

ASS STADA: Recent Clinical Evidence

Acetylsalicylic acid (ASA), the active ingredient in ASS STADA, has been the subject of continuous clinical research across its primary therapeutic areas: pain/fever relief and the prevention of cardiovascular events.


Research into Cardiovascular Event Prevention

In the context of secondary prevention (for patients who have already experienced a cardiovascular event, such as a myocardial infarction or stroke), research consistently supports the use of low-dose ASA to reduce the risk of recurrence. Studies suggest an approximate 25% reduction in the risk of recurrent thrombotic events in this population.

In the context of primary prevention (for patients without a history of cardiovascular disease), recent large-scale clinical trials have raised questions. These studies have found that while ASA may be associated with a reduced risk of cardiovascular events in certain patient groups (e.g., those with high baseline cardiovascular risk factors), this benefit must be carefully weighed against an increased risk of clinically significant bleeding events, particularly in older adults.


Evidence for Pain, Fever, and Tolerability

For its use in relieving acute pain and fever, research confirms ASA's established anti-inflammatory and antipyretic properties. A meta-analysis of data from clinical trials examining short-term, single-dose use found that ASA was associated with a small, but statistically significant, increase in the risk of dyspepsia (indigestion) relative to placebo. These findings highlight that, even at doses used for acute, over-the-counter relief, the potential for minor gastrointestinal adverse effects should be considered.

Regarding overall tolerability, studies have described the dose-dependent nature of ASA's effects on the gastrointestinal lining. Low daily doses (e.g., 75–100 mg) for long-term prevention induce significantly fewer gastroduodenal injuries than higher doses used for pain relief, though injury remains a recognized observation even at low doses.

Key Studies & References

  1. NICE Guideline: Myocardial infarction: cardiovascular disease (secondary prevention) in primary care.

Frequently Asked Questions (FAQ)

Common questions about ASS STADA (FAQ)

Q: What is the main difference between ASS STADA and basic aspirin?

A: ASS STADA is a specific brand of Acetylsalicylic acid (Aspirin) provided as a gastro-resistant tablet. This coating is a key formulation difference intended to prevent the tablet from dissolving in the stomach. According to official product information, this is designed to reduce the risk of irritation to the stomach lining compared to an uncoated, 'basic' aspirin tablet.

Q: Why is ASS STADA prescribed for heart health?

A: Regulatory documents state that Acetylsalicylic acid, the active ingredient, is classified as an antiplatelet agent. It is prescribed for heart health because it influences the body's natural process of blood clot formation. This action is associated with a reduced risk of certain cardiovascular events, such as a heart attack or stroke.

Q: Is it normal to feel a change in my body after starting ASS STADA?

A: Official documentation lists several common adverse reactions, including minor gastrointestinal discomfort, nausea, and minor bleeding tendencies. If you notice a feeling of change in your body, it may relate to these documented effects. Any unusual or concerning changes are best addressed by a medical professional.

Q: Can I take ASS STADA if I am already taking supplements?

A: Regulatory documents list interactions with specific herbal ingredients that are known to affect blood clotting. Therefore, it is important to disclose all dietary, vitamin, and herbal supplements you are taking to a healthcare provider. This allows them to assess any potential risks arising from combined use.

Q: Do I need to avoid certain foods or drinks while using ASS STADA?

A: Official documentation specifically warns that chronic, heavy consumption of alcohol can increase the risk of stomach bleeding. Aside from this, the product is generally recommended to be taken with or after meals. No other specific food restrictions are mandated in the official guidelines.

Q: What happens if I stop taking ASS STADA suddenly?

A: Stopping this medicine suddenly, particularly when used for cardiovascular prevention, may increase the risk of recurrent blood clot-related events due to a potential rebound in platelet activity. Decisions regarding discontinuation are made in consultation with a medical professional.

Q: Can people with kidney issues use ASS STADA?

A: The medicine is absolutely contraindicated (must not be used) in patients experiencing severe renal failure. Individuals with milder or chronic kidney conditions are advised that use should be with caution. High-dose or long-term NSAID use is documented to potentially affect kidney function.

Q: Is ASS STADA suitable for use during pregnancy, according to official information?

A: The use of regular-dose aspirin is officially contraindicated during the third trimester of pregnancy due to documented risks to the fetus and the mother. Use during the first and second trimesters is restricted and allowed only if a physician deems it medically necessary. Low-dose aspirin may be recommended by a doctor for specific high-risk pregnancy complications.

Q: Why is ASS STADA sometimes mentioned for pain relief, even if it's not its main use?

A: Acetylsalicylic acid, the active ingredient, carries a dual classification. It functions as an antiplatelet agent for cardiovascular prevention, but it is also a Nonsteroidal Anti-inflammatory Drug (NSAID). Official sources confirm its established properties for relieving mild-to-moderate pain and reducing fever, which is why it is mentioned for both uses.

Q: Has ASS STADA been studied in children or teenagers?

A: Official documentation heavily restricts the use of this medicine in children and adolescents. This is primarily due to the documented, rare but serious risk of Reye's syndrome when used during viral illnesses. For general pain or fever relief, use in this age group is generally contraindicated unless specifically advised by a physician.

Q: Is ASS STADA generally considered a long-term medicine?

A: According to official administration guidelines, this medicine has a dual usage protocol. For its anti-thrombotic effect in prevention, it is intended for long-term, chronic administration. Conversely, for pain and fever relief (the analgesic effect), it is intended for short-term, intermittent use.

Q: What do clinical studies say about ASS STADA's effectiveness for its approved uses?

A: Research consistently supports the use of the active ingredient for the secondary prevention of cardiovascular events in at-risk patients. Its efficacy for acute pain and fever relief is also confirmed by studies examining its established anti-inflammatory and antipyretic properties. Effectiveness is well-documented across its official therapeutic indications.

Q: Can ASS STADA cause allergic reactions, and what are the signs?

A: Official documentation notes that hypersensitivity reactions are an uncommon adverse effect, and severe reactions are rare. Signs may include sudden, severe, or itchy rash (hives), swelling of the face, throat, or tongue, or breathing difficulties. If these occur, consulting a medical professional immediately is necessary.

Q: Why might a doctor switch me from one aspirin product to ASS STADA?

A: A doctor may recommend a switch to an enteric-coated formulation like ASS STADA to help mitigate the risk of gastrointestinal irritation and bleeding. This formulation difference is designed to reduce stomach exposure to the medication. This is a primary clinical benefit for patients on continuous, long-term daily aspirin therapy who may have stomach sensitivity.

Q: Does ASS STADA interact with common over-the-counter pain relievers?

A: Co-administration with other Nonsteroidal Anti-inflammatory Drugs (NSAIDs) such as Ibuprofen and Naproxen is officially contraindicated. This combination carries an increased risk of severe gastrointestinal bleeding. However, official documents do not list an interaction with Acetaminophen (Paracetamol).

Q: Is ASS STADA available without a prescription in some places?

A: In many countries, low-dose acetylsalicylic acid products are available for purchase without a medical prescription. This non-prescription status is typically granted when the product is packaged specifically for its anti-thrombotic use. Availability depends on local regulatory classifications.

Q: Do any official documents mention using ASS STADA for stroke prevention?

A: Yes. Official regulatory documents and product labeling explicitly cite the use of the medicine for the secondary prevention of cerebrovascular ischemic events. This includes reducing the risk of recurrent stroke in appropriate patient populations.

Q: Can ASS STADA affect dental procedures or surgery?

A: Due to its antiplatelet effect, this medicine affects the body's natural blood clotting processes. Patients must inform their surgeon or dentist that they are taking ASS STADA before any procedure. The healthcare team will then assess if any changes to the medicine schedule are appropriate.

Q: Why do official sources state that some people should not use ASS STADA?

A: Official restrictions (contraindications) are put in place to manage the risk of severe complications. These are established primarily to prevent severe bleeding in at-risk patients and to avoid rare, specific complications in certain populations, such as Reye's syndrome in children with viral illness.

Q: What does the research say about the potential benefits of ASS STADA?

A: The documented benefits relate to its established capability to provide symptomatic relief for pain and fever. Furthermore, studies confirm its benefit in reducing the risk of recurrent cardiovascular events, such as heart attack or stroke, in at-risk patients.

Q: Is it possible to be allergic to the ingredients in ASS STADA?

A: Yes, it is possible. Official guidelines state that the medicine is contraindicated for patients with known hypersensitivity to the active ingredient (Acetylsalicylic acid) or other salicylates. It is also contraindicated for those with an allergy to any of the product's excipients (non-active ingredients).

Q: How is ASS STADA different from other medicines used for similar conditions?

A: The active ingredient, Acetylsalicylic acid, is unique among commonly used antiplatelet agents and NSAIDs. Regulatory documents state that it works through the irreversible inhibition of the COX-1 enzyme. This molecular action provides its distinct and lasting anti-clotting effect.

Q: Are there different strengths of ASS STADA available?

A: Yes. The medicine is commonly available as a 100 mg gastro-resistant tablet for long-term prevention. The active ingredient, Acetylsalicylic acid, is also available in higher strengths for short-term pain and fever relief.

Q: Is there a link between ASS STADA and ringing in the ears?

A: Tinnitus (ringing in the ears) is a recognized symptom of salicylate toxicity, which is the result of very high doses of the active ingredient. According to official warnings, it is highly unlikely to occur at the standard low doses used for cardiovascular prevention.

Q: What is the general expectation for how long it takes to see the therapeutic effects of ASS STADA?

A: For pain and fever relief, the therapeutic effects begin relatively quickly after administration. For the protective antiplatelet effect, the action on the platelet is immediate. However, the full, long-term protective benefit relies on the accumulation of continuous, daily use.

Q: Are there official restrictions on driving or operating machinery while taking ASS STADA?

A: Official guidance states that this medicine is generally considered to have no or negligible influence on the ability to drive and use machines. However, if side effects such as dizziness or headache occur, these activities are best avoided until the symptoms fully resolve.

Q: Does ASS STADA affect blood pressure?

A: This medication is not used as a treatment for high blood pressure. However, regulatory documents state that the medicine may diminish the hypotensive effect of certain prescribed antihypertensive medications, such as ACE inhibitors and diuretics.

Q: Can ASS STADA interfere with blood sugar monitoring?

A: Official documentation advises caution when this medicine is used by diabetic patients. Salicylic acid, the product of aspirin breakdown, may interfere with certain laboratory tests and blood sugar readings.

Q: Is ASS STADA commonly used by older adults?

A: The medicine is commonly used by older adults for secondary prevention (preventing a recurrence of a prior cardiovascular event). However, official guidelines advise caution in this population due to an increased risk of gastrointestinal adverse events associated with its use.

Q: What other medicines are known to interact with ASS STADA?

A: Documented interacting classes include Anticoagulants, other Antiplatelet Agents, Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Systemic Corticosteroids, and certain Antihypertensive medications. These interactions are primarily based on risks of increased bleeding or diminished drug efficacy.

How should ASS STADA be stored and disposed of?

How to Store and Dispose of ASS STADA?

The storage and disposal of ASS STADA 100 mg tablets must strictly follow the conditions defined in regulatory documentation.

Official Storage Requirements

Condition Type Requirement
Temperature Store at a temperature not exceeding 25 C
Protection Keep in the original packaging to protect from moisture
Child Safety Must be kept out of the sight and reach of children
Stability Do not use after the expiry date stated on the carton

Disposal Instructions

Medicines that are no longer needed must not be disposed of via wastewater (such as flushing down the toilet or pouring down the sink). Disposal must be handled in a manner that contributes to the protection of the environment. Unused or expired medicine should be properly discarded by asking a pharmacist for the correct disposal procedures.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of ASS STADA found in:

A-Z Index: